GlassScriptPhysician profile
Manana Elia
NPI 1609841816
$6,178.35
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $140 · 2021: $11.92 · 2022: $224 · 2023: $152 · 2024: $5,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,680 · Food and Beverage: $614 · Travel and Lodging: $482 · Education: $25.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,680.00 |
| Food and Beverage | $613.92 |
| Travel and Lodging | $482.45 |
| Education | $25.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $5,521.26 | 2021-2024 | Trodelvy |
| Astrazeneca Pharmaceuticals LP | $306.83 | 2023-2024 | Enhertu |
| Seagen INC. | $135.65 | 2020-2022 | |
| Daiichi Sankyo INC. | $117.14 | 2020 | |
| Novartis Pharmaceuticals Corporation | $76.29 | 2023 | |
| Merck Sharp & Dohme LLC | $21.18 | 2023 | Lynparza, Keytruda |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manana Elia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.